We are BarentsKrans

Our lawyers and notaries provide specialist legal services on a national and international scale. Our expertise covers litigation, advice and transactions. BarentsKrans is committed to quality; we deliver high levels of work and success rates. It also means that you can count on us: we work together with you throughout to achieve the best possible outcome. We call this ‘being dedicated’.

Watch video

News & publications

| Marleen van den Horst

Pharma update | NPS’s cinacalcet patent held valid by Court of Appeal

EP ‘761, owned by Shire-NPS Pharmaceuticals Inc. (‘NPS’), relates to the API cinacalcet, which is used for the treatment of conditions of impaired regulation of calcium levels in human blood and tissue fluid. The product is marketed under the name Mimpara®. In September 2017, Accord Healthcare Ltd. and Accord Healthcare B.V. (‘Accord’) initiated invalidity proceedings
Read more ›
| Thomas van Hövell tot Westervlier

BarentsKrans advises the directors of Quintes Holding on its sale to private equity investor Aquiline

BarentsKrans has advised the directors (also shareholders) of Quintes Holding B.V. on the sale of the shares in Quintes Holding B.V. to private equity investor Aquiline Capital Partners. Michiel Martin and Thomas van Hövell tot Westervlier were involved in this transaction. Quintes Holding is one of the largest independent insurance brokers in the Netherlands. Since
Read more ›
| Marleen van den Horst

Pharma update – 10 July 2020 | Supreme Court decides on pemetrexed & fulvestrant

In this Update we report on two recent judgments of the Dutch Supreme Court.  On 12 June 2020 a judgment was rendered on pemetrexed in the interim relief proceedings between Fresenius Kabi Nederland B.V. (“Fresenius”) and Eli Lilly & Company(“Lilly”).  On 26 June 2020, the Supreme Court decided on fulvestrant in final relief proceedings between
Read more ›

Contact

Visiting address

Lange Voorhout 3
2514 EA Den Haag

Postal address

Postbus 30457
2500 GL Den Haag


More details